{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:46:47Z","timestamp":1790923607053,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.tiv.2009.05.021","type":"journal-article","created":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T08:41:56Z","timestamp":1244018516000},"page":"346-356","source":"Crossref","is-referenced-by-count":18,"title":["Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions"],"prefix":"10.1016","volume":"24","author":[{"given":"Catherine","family":"Abadie-Viollon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumrongsak","family":"Pekthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mantion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Heyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantz","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Coassolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2009.05.021_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1024614000925","article-title":"Influence of pre-, intra- and post-operative parameters of donor liver on the outcome of isolated human hepatocytes","volume":"3","author":"Alexandre","year":"2002","journal-title":"Cell and Tissue Banking"},{"issue":"5","key":"10.1016\/j.tiv.2009.05.021_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0091270003043005001","article-title":"Pharmaceutical research and manufacturers of America drug metabolism\/clinical pharmacology technical working groups. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective","volume":"43","author":"Bjornsson","year":"2003","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.tiv.2009.05.021_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0022-3565(25)38702-1","article-title":"Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture","volume":"269","author":"Curi-Pedrosa","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/j.tiv.2009.05.021_bib4","first-page":"1325","article-title":"Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes","volume":"29","author":"Drocourt","year":"2001","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.05.021_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","article-title":"Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity","volume":"28","author":"Faucette","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.05.021_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/dmd.32.3.348","article-title":"Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers","volume":"32","author":"Faucette","year":"2004","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.05.021_bib7","first-page":"1200","article-title":"Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor","volume":"317","author":"Faucette","year":"2006","journal-title":"Journal of Pharmacology and Experimental Toxicology"},{"key":"10.1016\/j.tiv.2009.05.021_bib8","series-title":"Isolated and Cultured Hepatocytes, Chapter 14","first-page":"313","article-title":"Use of isolated and cultured hepatocytes for xenobiotics and cytotoxicity studies","author":"Guillouzo","year":"1986"},{"key":"10.1016\/j.tiv.2009.05.021_bib1a","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004410100429","article-title":"Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell\u2013cell interactions","volume":"306","author":"Hamilton","year":"2001","journal-title":"Cell Tissue Research"},{"issue":"4","key":"10.1016\/j.tiv.2009.05.021_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/clpt.1987.168","article-title":"The mechanism of the warfarin\u2013rifampin drug interaction in humans","volume":"42","author":"Heimark","year":"1987","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.tiv.2009.05.021_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metabolism Reviews"},{"issue":"10\u201311","key":"10.1016\/j.tiv.2009.05.021_bib11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1080\/00498250701534893","article-title":"Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro\u2013in vivo correlations","volume":"37","author":"Hewitt","year":"2007","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.tiv.2009.05.021_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2006.12.009","article-title":"Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry \u2013 Do they comply with FDA recommendations?","volume":"168","author":"Hewitt","year":"2007","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.tiv.2009.05.021_bib13","unstructured":"Huang, S.-M., 2004. Drug interaction studies \u2013 Study design, data analysis, and implications for dosing and labelling. Preliminary Concept Paper, October 2004."},{"key":"10.1016\/j.tiv.2009.05.021_bib14","unstructured":"Huang, S.-M., Stifano, T., 2006. Guidance for Industry: Drug interaction studies \u2013 Study design, data analysis, and implications for dosing and labelling. Draft Guidance, September, 2006. <http:\/\/www.fda.gov\/cber\/gdlns\/interactstud.htm>."},{"issue":"20","key":"10.1016\/j.tiv.2009.05.021_bib15","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1073\/pnas.81.20.6378","article-title":"Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically defined medium","volume":"81","author":"Isom","year":"1984","journal-title":"Proceedings of the National Academy of Science, USA"},{"issue":"4","key":"10.1016\/j.tiv.2009.05.021_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tiv.2009.05.021_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4","article-title":"Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes","volume":"14","author":"LeCluyse","year":"2000","journal-title":"Journal of Biochemistry and Molecular Toxicology"},{"key":"10.1016\/j.tiv.2009.05.021_bib18","first-page":"207","article-title":"Isolation and culture of primary human hepatocytes","volume":"vol. 290","author":"LeCluyse","year":"2005"},{"issue":"6","key":"10.1016\/j.tiv.2009.05.021_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11095-006-0277-7","article-title":"CYP induction-mediated drug interactions: in vitro assessment and clinical implications","volume":"23","author":"Lin","year":"2006","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.tiv.2009.05.021_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.31.4.421","article-title":"Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes","volume":"31","author":"Madan","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.05.021_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-409X(96)00417-6","article-title":"The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man","volume":"22","author":"Maurel","year":"1996","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"3","key":"10.1016\/j.tiv.2009.05.021_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clpt.2003.10.003","article-title":"Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects","volume":"75","author":"Park","year":"2004","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.tiv.2009.05.021_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.taap.2004.01.010","article-title":"The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes","volume":"199","author":"Parkinson","year":"2004","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.tiv.2009.05.021_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0887-2333(01)00099-6","article-title":"Evaluation of the effect of culture configuration on morphology, survival, antioxidant status and metabolic capacities of cultured rat hepatocytes","volume":"16","author":"Richert","year":"2002","journal-title":"Toxicology in Vitro"},{"key":"10.1016\/j.tiv.2009.05.021_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1478-3231.2004.0930.x","article-title":"Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections","volume":"24","author":"Richert","year":"2004","journal-title":"Liver International"},{"key":"10.1016\/j.tiv.2009.05.021_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2008.11.019","article-title":"Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes","volume":"235","author":"Richert","year":"2009","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.tiv.2009.05.021_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tiv.2009.05.022","article-title":"Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers \u2013 A European Centre for Validation of Alternative Methods (ECVAM) \u2013 funded pre-validation study","volume":"24","author":"Richert","year":"2009","journal-title":"Toxicology in Vitro"},{"key":"10.1016\/j.tiv.2009.05.021_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0090-9556(24)15146-X","article-title":"In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil","volume":"28","author":"Robertson","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"issue":"4","key":"10.1016\/j.tiv.2009.05.021_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1994.49","article-title":"Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test","volume":"55","author":"Rost","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"11","key":"10.1016\/j.tiv.2009.05.021_bib30","first-page":"542","article-title":"Dose dependent induction of CYP1A2 activity by omeprazole (Antra)","volume":"30","author":"Rost","year":"1992","journal-title":"International Journal of Clinical Pharmacology and Therapeutic Toxicology"},{"issue":"7","key":"10.1016\/j.tiv.2009.05.021_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1124\/dmd.104.003046","article-title":"Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes","volume":"33","author":"Roymans","year":"2005","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.1016\/j.tiv.2009.05.021_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.tiv.2009.05.021_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0003-9861(89)90358-5","article-title":"Effects of cytochrome P450-inducing agents on the monooxygenation of testosterone in long-term cultures of hepatocytes from male and female rats","volume":"275","author":"Vind","year":"1989","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"5","key":"10.1016\/j.tiv.2009.05.021_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/dmd.31.5.620","article-title":"Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"issue":"11","key":"10.1016\/j.tiv.2009.05.021_bib35","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/0006-2952(90)90095-3","article-title":"The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers","volume":"40","author":"Wortelboer","year":"1990","journal-title":"Biochemical Pharmacology"},{"issue":"23","key":"10.1016\/j.tiv.2009.05.021_bib36","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Development"},{"issue":"2","key":"10.1016\/j.tiv.2009.05.021_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2002.tb00186.x","article-title":"Cytochromes P450 and experimental models of drug metabolism","volume":"6","author":"Zuber","year":"2002","journal-title":"Journal of Cellular and Molecular Medicine"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233309001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233309001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T21:41:41Z","timestamp":1739137301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233309001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0887233309001258"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2009.05.021","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}